Press Releases

ELEVAI Labs Releases Global Distribution Partnership Overview Featuring $4.9 Million in Potential Top Line Revenue Commitments

The company’s international distribution agreements have a contracted cumulative minimum purchase requirement of up to $4.9 million over the first…

Read More »

ELEVAI Labs Signs International Distribution Agreement to Enter Taiwan Market

The Asia-Pacific market represents a $13 billion prestige skincare and luxury haircare market opportunity, with the Taiwan deal giving the…

Read More »

ELEVAI Labs Reports Strong Preliminary Unaudited Financials for Fiscal Year 2023

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced certain preliminary, unaudited management-prepared financial results for…

Read More »

ELEVAI Labs Signs Worldwide License Deal for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an…

Read More »

ELEVAI Labs to Participate in Upcoming Aesthetic Industry Conferences

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announces participation in three aesthetic industry conferences in…

Read More »

XTM Signs Deal to Acquire World-Class Earned Wage Access Company QRails

XTM Inc. (CSE: PAID) (OTCQB: XTMIF) (FSE: 7XT), a Miami and Toronto-based Fintech creator of payment innovations and mobile solutions…

Read More »

XTM Plans Acquisition of World-Class Earned Wage Access Company QRails

XTM Inc. (CSE: PAID) (OTCQB: XTMIF) (FSE: 7XT), a Miami and Toronto-based Fintech creator of disruptive payment innovations and mobile…

Read More »

XTM Announces $5 Million Financing

XTM (CSE: PAID) (OTCQB: XTMIF) (FSE: 7XT), a Miami and Toronto-based Fintech creator of disruptive payment innovations specifically for service…

Read More »

Chanson International Holding Announces Pricing of IPO

The “Offering” of 3,390,000 Class A ordinary shares at a public offering price of US$4.00 per Class A ordinary share.…

Read More »

Safe Supply Streaming and Origin Therapeutics Engage Research Capital, Announce Financing Upsized to $4 Million

Safe Supply Streaming Co. and Origin Therapeutics (CSE: ORIG) (FSE: U8B) announced today the upsizing of the companies’ previously disclosed private…

Read More »
Back to top button